WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke HAEMATOKINE wurde als Wortmarke am 05.02.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1596176 |
| Registernummer | 018286902 |
| Länder | 
|
| Basismarke |
Nr. 018286902,
11. Dezember 2020
|
| Anmeldedatum | 05. Februar 2021 |
| Ablaufdatum | 05. Februar 2031 |
Markeninhaber
Joukahaisenkatu 6
20520 Turku
FI
20520 Turku
FI
Markenvertreter
Eteläinen Rautatiekatu 10 A
00100 Helsinki
FI
Waren und Dienstleistungen
01
Chemicals for use in industry, science and photography, as
well as in agriculture, horticulture and forestry;
biological preparations for use in industry and science;
media for cell culture for use in the biotechnological
industry; media for cell culture for use in non-medical
research laboratories; biological preparation for use in
cell cultures other than for medical or veterinary use;
culture media for microbiology; cell growth media for
growing cells for scientific use; cultures, other than for
medical or veterinary use; cultures of cell media [other
than for medical or veterinary use]; cultures of
microorganisms, other than for medical and veterinary use;
blood culture media for scientific use; biological
preparations, other than for medical or veterinary purposes;
stem cells, other than for medical or veterinary purposes;
stem cells for scientific purposes; stem cells for research
purposes
05
Pharmaceuticals, medical and veterinary preparations;
sanitary preparations for medical purposes; stem cells; stem
cells for medical purposes; tumor suppressing agents;
antineoplastics; anti-neoplastic preparations of chemical
origin; anti-neoplastic preparations of microbial origin;
anti-cancer preparations; compounds for treating cancer;
antibodies; antibodies for medical use to treat inflammation
and cancer growth and spread; adjuvants for medical
purposes; vaccine adjuvants; biological adjuvants for
medical purposes; anti-inflammatories; antigens; antitumor
drugs; biological preparations for the treatment of cancer;
biopharmaceuticals for the treatment of cancer;
biotechnological preparations for medical use; culture media
for medical use; media for bacteriological cultures; cell
growth media for growing cells for medical use; biological
preparations for medical purposes; mixed biological
preparations for medical purposes; biological preparations
for veterinary purposes; immunomodulators; immunostimulants;
injectable pharmaceuticals; pharmaceutical preparations for
the treatment of viral diseases; pharmaceutical preparations
for the treatment of bone diseases; pharmaceutical
preparations for use in chemotherapy; pharmaceutical
preparations for the treatment of infectious diseases;
pharmaceutical preparations for the treatment of immune
system related diseases and disorders; pharmaceutical
preparations for use in oncology; pharmaceutical
preparations for activating cellular function;
pharmaceutical preparations for immunity adjustment;
pharmaceutical preparations for regulating the immune
system; pharmaceutical preparations for treating malignant
tumors; pharmaceutical preparations for suppressing tumors;
pharmaceutical preparations for the treatment of autoimmune
diseases; pharmaceutical preparations for the prevention of
tumours; pharmaceutical preparations and substances for use
in oncology; pharmaceutical preparations and substances with
anti-inflammatory properties; pharmaceutical preparations
and substances for the treatment of cancer; pharmaceutical
preparations for the treatment of autoimmune disorders;
pharmaceutical preparations for use in hematology;
pharmaceutical preparations for the prevention of diseases
of the immune system; pharmaceutical preparations for the
prevention of disorders of the immune system; pharmaceutical
preparations for the prevention of autoimmune diseases;
pharmaceutical preparations for the treatment of disorders
caused by bacteria; pharmaceutical preparations for the
treatment of diseases caused by bacteria; pharmaceutical
preparations for the prevention of disorders of the
respiratory system; pharmaceutical preparations for the
prevention of inflammatory disorders; pharmaceutical
preparations for the prevention of autoimmune disorders;
pharmaceutical preparations for the prevention of
inflammatory diseases; pharmaceutical preparations for the
treatment of inflammatory diseases; pharmaceutical
preparations for the treatment of cancer; pharmaceutical
preparations for use in tissue transplantation;
pharmaceutical products for the treatment of bone diseases;
regulatory proteins for medical use; serotherapeutic
medicines; synthetic peptides for pharmaceutical purposes;
pharmaceutical products for treating respiratory diseases;
compounds for treating respiratory diseases; pharmaceutical
preparations for treating respiratory diseases; compounds
for treating correlated pulmonary syndromes; pharmaceutical
preparations for treatment and prevention of ischemic
conditions, inflammation and organ damages resulting from
tissue traumas, reperfusion injuries, cancer, cancer
metastasis, inflammatory conditions and allergic conditions;
pharmaceutical preparations for treatment and prevention of
multi-organ failure, acute lung injury and acute respiratory
distress syndrome in adults, adolescents, children, infants
and neonates
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 02. August 2023 | 2023/31 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| 01. Dezember 2022 | 2022/49 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 15. September 2022 | 2022/38 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 09. September 2022 | 2022/37 Gaz | CA | Ablehnung |
| 23. August 2022 | 2022/34 Gaz | KR | Ablehnung |
| 05. Mai 2022 | 2022/18 Gaz | CH | Ablehnung |
| 07. April 2022 | 2022/14 Gaz | JP | Ablehnung |
| 30. November 2021 | 2021/49 Gaz | NZ | Ablehnung |
| 29. November 2021 | 2021/50 Gaz | RAW: Limitation | |
| 22. Oktober 2021 | 2021/45 Gaz | CN | Ablehnung |
| 27. September 2021 | 2021/39 Gaz | US | Ablehnung |
| 26. August 2021 | 2021/34 Gaz | AU | Ablehnung |
| 28. Juni 2021 | 2021/27 Gaz | IN | Ablehnung |
| 05. Februar 2021 | 2021/21 Gaz | EM | Eintragung |
ID: 141596176